CannaMD

MAY 28, 2021

To review The Botanist’s COVID-19 delivery/pick-up and safety policies, please see: Florida Dispensaries: Coronavirus Policies. To review Columbia Care’s COVID-19 delivery/pick-up and safety policies, please see: Florida Dispensaries: Coronavirus Policies. The Botanist has not publicized any sales at this time. Columbia Care.

Safety 97

Safety Policy Marijuana Dispensary 97

SpeedWeed

FEBRUARY 21, 2021

February 18, 2021. | The post Cannabis mixtures studied as treatment for COVID inflammation appeared first on SpeedWeed. Published. James Hale. CRS, MAS, and ARDS are the leading causes of death among those who become infected with the SARS-CoV-2 virus.

Treatment 52

Treatment Research and Development Cannabinoids Data 52

Cannabis Law Report

DECEMBER 7, 2021

Scientific Reports volume 11 , Article number: 23462 ( 2021 ) Cite this article. Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. Metrics details.

Safety 52

Safety Cannabinoids Events Data 52

MMJ Recs

NOVEMBER 11, 2020

Which countries have been taking steps towards medical marijuana (MMJ) legalization that could potentially be finalized in 2021 or shortly after? This question is being asked by patients all over the world who would see a massive benefit in their quality of life if they could avail of medical marijuana treatment.

Legalization 52

Legalization Decriminalization Marijuana Epilepsy 52

TheAnswerPage

OCTOBER 17, 2021

Are there any state laws that allow patients to use medical cannabis-based products in hospitals and certain healthcare facilities? In September 2021, California Governor G. It does NOT apply to patients receiving emergency care, and smoking and vaping cannabis is expressly PROHIBITED.

Treatment 52

Treatment Patients Compliance Compliance 52

Cannabis Law Report

JUNE 12, 2021

Road safety risks associated with medicinal cannabis appear similar or lower than numerous other potentially impairing prescription medications. The application of presence-based offences to medicinal cannabis patients appears to derive from the historical status of cannabis as a prohibited drug with no legitimate medical application.

Policy 66

Policy Safety Medicine Access 66

TheAnswerPage

OCTOBER 6, 2021

According to a JAMA Open Network article published in September 2021, in a “nonrandomized controlled trial, CBD transdermal gel was well tolerated over 6.5 months of treatment, with 60% of patients experiencing a treatment-related adverse event, 96% of which were mild or moderate. JAMA Netw Open. 2021;4(9):e2123930.

Sleep 52

Sleep Treatment Concentrates Safety 52

Cannabis Law Report

AUGUST 12, 2021

Net loss for the six months ended 30 June 2021 was $30.2 Net loss for the six months ended 30 June 2021 was $30.2 Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. On track to report top-line data by end of 2021.

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

TheAnswerPage

OCTOBER 21, 2021

According to the European Pain Federation position paper on the appropriate use of cannabis-based medicines, “a testing period of maximum 3 months should be considered both by patients and prescribers [or recommenders], to assess treatment efficacy and safety. At the end of this testing period, long?term

Chronic Pain 59

Chronic Pain Treatment Therapy Safety 59

The Blunt Truth

JANUARY 5, 2022

Below are some highlights of what happened in 2021. On June 22, 2021, Connecticut legalized recreational marijuana use by adults 21 years and older. On April 12, 2021, New Mexico saw the legalization of recreational marijuana. Now is no different. Connecticut. There are numerous positions and industries exempt from the law.

Law 105

Law Marijuana Policy Recreational 105

Cannabis Law Report

OCTOBER 15, 2021

DNA variations or polymorphisms) in patients with African ancestry. The KGA is a proprietary computational platform built in-house at Goldfinch Bio to identify genetic and environmental causes of kidney diseases in patient subsets and the associated biological targets for therapeutic intervention. Poster Number: INFO37.

Clinical Trials 52

Clinical Trials Research and Development Data Patients 52

Cannabis Law Report

JUNE 12, 2021

Authors’ Abstract for Arkell, McCartney & McGregor (2021). Patients and physicians need to be aware of the important implications that such use may have for driving. Patients using THC-containing products should avoid driving and other safety-sensitive tasks (e.g., Arkell 2021 Med Cannab & GPs.

Patients 105

Patients THC Safety Treatment 105

TheAnswerPage

NOVEMBER 23, 2021

What are the most common reasons for breast cancer patients undergoing adjuvant and palliative radiation therapy to use medical marijuana products? Patients undergoing palliative radiation were more likely to use cannabis to relieve chronic pain compared to patients undergoing adjuvant radiation. ” Marco Meglio [link].

Chronic Pain 52

Chronic Pain Therapy Patients Safety 52

TheAnswerPage

OCTOBER 18, 2021

Are there any strategies in which patients with chronic non-cancer pain can find their optimal dosing regimen without consuming high doses of THC? We do not regard cannabinoids as first-line treatments but as adjuvant therapies to be used before opioids if other options fail to control chronic non-cancer pain.

Chronic Pain 52

Chronic Pain Therapy Cannabinoids Extraction 52

Veriheal

NOVEMBER 10, 2020

The experiment consists of a two-year cycle where up to 3,000 patients will be treated with medical cannabis. The experiment will only last two years long and is set to start with the first prescription in March 2021. This means that patients with prescriptions from a licensed physician may consume and possess cannabis.

Chronic Pain 76

Chronic Pain Pharmaceutical Patients Epilepsy 76

TheAnswerPage

NOVEMBER 30, 2021

According to the CSA, schedule I substances have a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision. THC is also a schedule I substance.)

Clinical Trials 52

Clinical Trials Safety Treatment THC 52

Cannabis Law Report

AUGUST 25, 2021

Both locations reflect Trulieve’s commitment to ensuring medical cannabis patients across Florida have safe, reliable access to the medications they rely on. ANNOUNCING : Trulieve Boynton Beach Grand Opening WHERE : 330 Winchester Park Blvd, Suite B, Boynton Beach FL 33436 WHEN : Thursday, August 26, 2021 , at 9:00 a.m.

Dispensary 105

Dispensary Patients Tincture Access 105

Cannabis Law Report

JUNE 21, 2021

In the medical cannabis industry, mostly due to the plant’s long history of prohibition, there is a decided lack of data regarding the use and efficacy of cannabis as a treatment for a wide variety of indications. The most recent one , from June 2021, takes a look at patients using cannabis to relieve pain. RYAH Group Inc.

Data 105

Data Clinical Trials Research and Development Indica 105

Cannabis Law Report

JUNE 4, 2021

– Drug Demonstrates Efficacy and Safety in Advanced Prostate Cancer Patients. NEW YORK , June 4, 2021 /PRNewswire/ — AIkido Pharma Inc. Nasdaq: AIKI ) (“AIkido” or the “Company”) today announced that positive Phase 1 testing data was presented at the 2021 ASCO Annual Meeting June 4 , 2021.

Data 100

Data Research and Development Clinical Trials Therapy 100

Cannabis Law Report

AUGUST 4, 2021

The Core Business delivered strong organic growth 13 in H1 2021 (17% year-on-year) despite some of Eurofins’ businesses remaining affected by lockdowns during H1 2021. The Core Business delivered strong organic growth 13 in H1 2021 (17% year-on-year) despite some of Eurofins’ businesses remaining affected by lockdowns during H1 2021.

Business 105

Business Research and Development Environment Food 105

Cannabis Law Report

AUGUST 17, 2021

reduction in 28-day seizure frequency relative to baseline in tuberous sclerosis complex (TSC) patients (n=23). reduction was observed in focal seizures (n=19), the most common seizure type in TSC patients. Phase 3 planning for TrustTSC trial ongoing with first patient expected to be enrolled in Q4 2021. RADNOR, Pa.–(BUSINESS

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Cannabis Law Report

FEBRUARY 26, 2022

The organization has, they say, ……evaluated patient access, affordability, equity, and product safety. With a decline in legislative improvements in state medical cannabis programs, millions of patients are left with limited or no access,” ASA Executive Director Debbie Churgai said. “It Pennsylvania State Rep.

Access 98

Access Law Patients Programs 98

Cannabis Law Report

DECEMBER 26, 2021

December 17, 2021 ·. – December 16, 2021) – Entheon Biomedical Corp. 63/283,051, titled “Detection of Therapeutic Psychedelic State,” as of November 23, 2021. 63/283,051, titled “Detection of Therapeutic Psychedelic State,” as of November 23, 2021. US Provisional Patent Filed.

Research and Development 52

Research and Development Clinical Trials Treatment Packaging 52

Cannabis Law Report

JANUARY 3, 2022

Below are some highlights of what happened in 2021. On June 22, 2021, Connecticut legalized recreational marijuana use by adults 21 years and older. On April 12, 2021, New Mexico saw the legalization of recreational marijuana. Now is no different. Jennifer Mora. Connecticut. New Mexico. New Jersey.

Law 52

Law Marijuana Policy Recreational 52

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

SpeedWeed

MARCH 6, 2021

Cannabis Voter Project (@Cannabis_Voter) March 3, 2021. Public safety at issue. Proponents of these THC caps—who are often the same politicians who stood against legalization and lost—contend that limiting THC levels will increase public safety. Forcing patients to purchase more. NORML (@NORML) March 4, 2021.

THC 52

THC Patients Law Chronic Pain 52

Cannabis Law Report

SEPTEMBER 15, 2021

More than 100 people in the US have been hospitalized in 2021 after using Delta-8 THC products, federal health regulators warned Tuesday. Of the 22 patients, 19 experienced adverse events after ingesting delta-8 THC-containing food products (e.g., 39% involved pediatric patients less than 18 years of age. brownies, gummies).

THC 105

THC Pets Events Hemp 105

Cannabis Law Report

OCTOBER 29, 2021

NYSE American: IGC) announces its financial results for the three months ended September 30, 2021, which is the second quarter of the Company’s 2022 fiscal year. The primary endpoint of this Phase 1 trial was safety and tolerability. During the six months ended September 30, 2021, the Company raised approximately $4.1

Clinical Trials 52

Clinical Trials Research and Development Data Business 52

Cannabis Law Report

JUNE 14, 2022

PAREA is a non-profit, multistakeholder and multidisciplinary partnership bringing together patient organizations, medical associations, scientific societies, psychedelic foundations, and the for-profit sector. The good news is that innovations that completely change the lives of patients continue to emerge.

Access 52

Access Therapy Clinical Trials Treatment 52

Cannabis Law Report

JUNE 1, 2021

TORONTO, June 01, 2021 (GLOBE NEWSWIRE) — via InvestorWire – RYAH Group, Inc. The 5-year study is expected to cover tens of thousands of patients suffering from chronic pain, which makes it one of the largest and most ambitious research projects to be conducted in the plant-based treatment arena.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

SEPTEMBER 1, 2021

This number also underscores the entire agency’s tireless efforts, particularly those of our hardworking staff, to thoughtfully regulate a safe, accessible, and effective adult-use marketplace that keeps critical tenets of our mission – public health, public safety, and equity, among others – front of mind.”. Licensing, Agents, and Equity.

Marijuana 100

Marijuana Seed-To-Sale Safety Data 100

Cannabis Law Report

FEBRUARY 17, 2022

WORCESTER – The Cannabis Control Commission (Commission) is alerting patients and consumers to its quarantine order (Order), issued October 18, 2021, mandating that ACK Natural, LLC, a colocated medical- and adult-use licensee, recall all products with unverifiable mycotoxin test results sold to its consumers and patients.

Marijuana 52

Marijuana Seed-To-Sale Safety Patients 52

Cannabis Law Report

SEPTEMBER 23, 2021

This Was the World’s First Published Study Assessing MDMA-Assisted Psychotherapy as a Treatment for Addiction. Toronto, Ontario, Sep 23, 2021 (Newsfile Corp via COMTEX) — Toronto, Ontario–(Newsfile Corp. – September 23, 2021) – Awakn Life Sciences Corp., (NEO: Treatment of AUD rates are low at 16%.

Research and Development 52

Research and Development Therapy Treatment Data 52

TheAnswerPage

JULY 21, 2022

An international guideline development panel including patients, clinicians with content expertise, and methodologists addressed the question: “What is the role of medical cannabis or cannabinoids for people living with chronic pain due to cancer or non-cancer causes? ” What recommendation was formulated by the research panelists?

Chronic Pain 52

Chronic Pain Research and Development Cannabinoids Safety 52

NORML

JANUARY 19, 2020

The bills would also allow for the expungement of certain prior convictions, delivery of medical marijuana to qualified patients, and restructures the medical marijuana licensure process to eliminate the requirement that business be vertically integrated. Send a message to your lawmakers in support of strengthening patient protections.

Legislation 244

Legislation Decriminalization Access Patients 244

Cannabis Law Report

JANUARY 21, 2022

Our final 2021 looking back and looking forward episode. Liz Rogan has been assisting cannabis business owners, counseling medical cannabis patients, and educating the public about the use of cannabis for the past 17 years. Sit back relax and enjoy our guests mulling over the past, present & future. In order of appearance.

Research and Development 52

Research and Development Education Advocacy Policy 52

Cannabis Law Report

JANUARY 20, 2022

SAP allows health care professionals to request access to non-marketed drugs and medical devices not yet authorized for sale in Canada, on behalf of a patient. 2 Regulatory Impact Analysis Statement, SOR/2021-271, Canada Gazette Part II , Vol. 2 Regulatory Impact Analysis Statement, SOR/2021-271, Canada Gazette Part II , Vol.

Access 52

Access Programs Treatment Therapy 52